Patent · US Active

Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

US8883837B2 · kind B2 · utility

0Cited by

6References

28Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Jean-François Bonfanti · Andé, FR
Koenraad Jozef Lodewijk Marcel Andries · Beerse, BE
Jérôme Michel Claude Fortin · Igoville, FR
Philippe Muller · Val-de-Reuil, FR
Frédéric Marc Maurice Doublet · Isneauville, FR
Christophe Meyer · Oissel, FR
Rudy Edmond Willebrords · Merksplas, BE
Tom Valerius Josepha Gevers · Vosselaar, BE
Philip Maria Martha Bern Timmerman · Hasselt, BE

Key dates

Filing date	Jun 17, 2008
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Nov 29, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention concerns morpholinyl containing benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formulaa prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof. It further concerns the preparation thereof and compositions comprising these compounds, as well as the use thereof as a medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.